LeadIQ logo
Learn more at LeadIQ.com

Insights

Gene Editing Technology Innovation Graphite Bio's pioneering UltraHDR™ gene editing platform offers a unique precision gene editing approach, providing sales opportunities for institutions looking to invest in cutting-edge technology for genetic mutation correction and gene therapy development.

Strategic Partnerships and Mergers Recent partnerships and mergers such as the collaboration with Lenz Therapeutics open up potential sales avenues for Graphite Bio to expand its gene editing capabilities and reach new markets, presenting opportunities for cross-selling products and services.

Therapy Development in Genetic Disorders Graphite Bio's development of therapies like GPH102 for beta thalassemia creates sales prospects for pharmaceutical companies seeking innovative solutions for genetic blood disorders, offering collaboration opportunities in research and drug development.

Clinical Study Launches The initiation of CEDAR study for nulabeglogene autogedtemcel in sickle cell disease demonstrates Graphite Bio's commitment to advancing potential cures, presenting sales opportunities for clinical trial services, patient monitoring tools, and medical equipment providers.

Financial Stability and Funding With a solid revenue range of $10M-50M and a funding of $151M, Graphite Bio's financial health reinforces trust in its sustainability and growth, attracting potential investors and partners interested in long-term collaborations and investments.

Similar companies to Graphite Bio

Graphite Bio Tech Stack

Graphite Bio uses 8 technology products and services including cdnjs, Squarespace, jQuery Migrate, and more. Explore Graphite Bio's tech stack below.

  • cdnjs
    Content Delivery Network
  • Squarespace
    Content Management System
  • jQuery Migrate
    Javascript Libraries
  • Amazon Web Services
    Platform As A Service
  • Yoast SEO
    Search Engines
  • Google Tag Manager
    Tag Management
  • Coupa
    Travel And Expense Management
  • Apache
    Web Servers

Media & News

Graphite Bio's Email Address Formats

Graphite Bio uses at least 1 format(s):
Graphite Bio Email FormatsExamplePercentage
FLast@graphitebio.comJDoe@graphitebio.com
96%
F.Last@graphitebio.comJ.Doe@graphitebio.com
2%
First-Last@graphitebio.comJohn-Doe@graphitebio.com
1%
LastFir@graphitebio.comDoeJoh@graphitebio.com
1%

Frequently Asked Questions

Where is Graphite Bio's headquarters located?

Minus sign iconPlus sign icon
Graphite Bio's main headquarters is located at 201 Haskins Way Suite 210 South San Francisco, CA 94080 US. The company has employees across 4 continents, including North AmericaAfricaOceania.

What is Graphite Bio's stock symbol?

Minus sign iconPlus sign icon
Graphite Bio is a publicly traded company; the company's stock symbol is LENZ.

What is Graphite Bio's official website and social media links?

Minus sign iconPlus sign icon
Graphite Bio's official website is graphitebio.com and has social profiles on LinkedIn.

How much revenue does Graphite Bio generate?

Minus sign iconPlus sign icon
As of August 2024, Graphite Bio's annual revenue reached $15M.

What is Graphite Bio's SIC code NAICS code?

Minus sign iconPlus sign icon
Graphite Bio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Graphite Bio have currently?

Minus sign iconPlus sign icon
As of August 2024, Graphite Bio has approximately 51 employees across 4 continents, including North AmericaAfricaOceania. Key team members include Chief Scientific Officer: J. G.Chief Operating Officer: J. C.Chief Operating Officer: K. S.. Explore Graphite Bio's employee directory with LeadIQ.

What industry does Graphite Bio belong to?

Minus sign iconPlus sign icon
Graphite Bio operates in the Biotechnology Research industry.

What technology does Graphite Bio use?

Minus sign iconPlus sign icon
Graphite Bio's tech stack includes cdnjsSquarespacejQuery MigrateAmazon Web ServicesYoast SEOGoogle Tag ManagerCoupaApache.

What is Graphite Bio's email format?

Minus sign iconPlus sign icon
Graphite Bio's email format typically follows the pattern of . Find more Graphite Bio email formats with LeadIQ.

How much funding has Graphite Bio raised to date?

Minus sign iconPlus sign icon
As of August 2024, Graphite Bio has raised $151M in funding. The last funding round occurred on Mar 15, 2021 for $151M.

When was Graphite Bio founded?

Minus sign iconPlus sign icon
Graphite Bio was founded in 2020.
Graphite Bio

Graphite Bio

Biotechnology ResearchCalifornia, United States51-200 Employees

Graphite Bio is a clinical-stage, next-generation gene editing company driven to discover and develop cures for a wide range of serious and life-threatening diseases. The company is pioneering a precision gene editing approach that has the potential to transform human health by achieving one of medicine’s most elusive goals: to precisely “find & replace” any gene in the genome. Graphite Bio’s UltraHDR™ gene editing platform takes CRISPR beyond cutting and harnesses the power of high-efficiency precision DNA repair, also known as homology-directed repair (HDR), to precisely correct genetic mutations, replace entire disease-causing genes with functional genes or insert new genes into predetermined, safe locations. Additionally, the company is advancing the development of novel conditioning regimens to help bring curative therapies to more patients. The company was co-founded by academic pioneers in the fields of gene editing and gene therapy, including Maria Grazia Roncarolo, M.D., and Matthew Porteus, M.D., Ph.D.

See our Community Guidelines at bit.ly/3c5Pztz. 

Section iconCompany Overview

Headquarters
201 Haskins Way Suite 210 South San Francisco, CA 94080 US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
LENZ
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
51-200

Section iconFunding & Financials

  • $151M

    Graphite Bio has raised a total of $151M of funding over 2 rounds. Their latest funding round was raised on Mar 15, 2021 in the amount of $151M.

  • $10M$50M

    Graphite Bio's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $151M

    Graphite Bio has raised a total of $151M of funding over 2 rounds. Their latest funding round was raised on Mar 15, 2021 in the amount of $151M.

  • $10M$50M

    Graphite Bio's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.